Current Opinion in Infectious Diseases

Article	Citations
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination	65
Skin manifestations of Pseudomonas aeruginosa infections	57
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection	38
Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections	31
Antimicrobial-resistant bacteria in international travelers	29
Parental vaccine hesitancy: scope, causes, and potential responses	27
Techniques in bacterial strain typing: past, present, and future	26
Long COVID in children and adolescents	26
Choosing antibiotic therapy for severe community-acquired pneumonia	23
Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis	22
Zoonoses and global epidemics	22
Potential and demonstrated impacts of the COVID-19 pandemic on sexually transmissible infections	21
Viral meningitis and encephalitis: an update	21
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	20
Risks of metabolic syndrome and diabetes with integrase inhibitor-based therapy	20
New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections	20
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	19
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes	19
Emerging treatment options for cryptosporidiosis	19
Hospital water as the source of healthcare-associated infection and antimicrobial-resistant organisms	18
Melioidosis and Burkholderia pseudomallei: progress in epidemiology, diagnosis, treatment and vaccination	18
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	18
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	18
MDRO transmission in acute hospitals during the COVID-19 pandemic	18
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-19	18

Gram-negative endocarditis: disease presentation, diagnosis and treatment	17
Staphylococcus aureus infections in children	17
New testing guidelines for community-acquired pneumonia	17
Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials	16
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity	15
Coronavirus disease 2019 vaccination in transplant recipients	15
Typhoid fever control in the 21st century: where are we now?	15
COVID-19 transmission and the safety of air travel during the pandemic: a scoping review	14
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	14
Respiratory metagenomics: route to routine service	14
Predictors of multidrug resistant Pseudomonas aeruginosa involvement in bloodstream infections	14
Dengue vaccine development: challenges and prospects	14
What will it take to meet UNAIDS targets for preexposure prophylaxis users?	13
Prevention of SARS-CoV-2 and respiratory viral infections in healthcare settings: current and emerging concepts	13
Mycobacterial skin infection	13
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients	13
Skin manifestations in patients with coronavirus disease 2019	13
mRNA vaccines against respiratory viruses	12
Management dilemmas in Nocardia brain infection	12
Nonviral sexually transmitted infections in pregnancy: current controversies and new challenges	12
Diagnosis of invasive fungal disease in coronavirus disease 2019: approaches and pitfalls	12
Long-acting injectable HIV therapies: the next frontier	12
Frailty in people living with HIV: an update	12
Cytomegalovirus in primary immunodeficiency	12
Siderophores: a potential role as a diagnostic for invasive fungal disease	12
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli	12
Amebic encephalitis and meningoencephalitis: an update on epidemiology, diagnostic methods, and treatment	11
Neurologic aspects of coronavirus disease of 2019 infection	11
Respiratory syncytial virus infection in the modern era	11
Echocardiography and FDG-PET/CT scan in Gram-negative bacteremia and cardiovascular infections	10
Pneumonia in older adults	10
Lenacapavir and the novel HIV-1 capsid inhibitors: an emerging therapy in the management of multidrug-resistant HIV-1 virus	10
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	10
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	10
Hyperammonemia syndrome in immunosuppressed individuals	10
Neurodevelopmental outcomes in congenital and perinatal infections	10
Nontyphoidal Salmonella infections acquired from poultry	9
Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections	9
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?	9
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections	9
Dose optimisation of antibiotics used for meningitis	9
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	9
Neuroradiology of infectious diseases	9
Immunotherapeutic approaches to HIV cure and remission	9
Emergence of a novel urogenital-tropic Neisseria meningitidis	9
Antiviral therapies for influenza	9
Effects of HIV voluntary medical male circumcision programs on sexually transmitted infections	9
Managing uncertainty in antifungal dosing: antibiograms, therapeutic drug monitoring and drug-drug interactions	8
Neurobrucellosis	8
The disease burden of respiratory syncytial virus in older adults	8

Noninvasive ventilation and high-flow oxygen therapy for severe community-acquired pneumonia	8
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	8
Conjunctival cancer in people living with HIV	8
Neurocysticercosis: an update on diagnosis, treatment, and prevention	8
Multidrug-resistant, gram-negative infections in high-risk haematologic patients: an update on epidemiology, diagnosis and treatment	8
Bacterial RTX toxins and host immunity	8
Role or oritavancin and dalbavancin in acute bacterial skin and skin structure infections and other potential indications	8
Pregnancy and malaria: the perfect storm	7
Antimicrobial use in central nervous system infections	7
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges	7
Severe acute respiratory syndrome coronavirus 2 infection in the stem cell transplant recipient − clinical spectrum and outcome	7
Current international and national guidelines for managing skin and soft tissue infections	7
Predisposition of COVID-19 patients to secondary infections: set in stone or subject to change?	7
Congenital cytomegalovirus infection diagnostics and management	7
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	7
MDR/XDR/PDR or DTR? Which definition best fits the resistance profile of Pseudomonas aeruginosa?	7
Arboviral central nervous system infections	7
Potential role of new-generation antibiotics in acute bacterial skin and skin structure infections	7
Rectal chlamydia infections: implications for reinfection risk, screening, and treatment guidelines	7
Current opinion in management of septic shock due to Gram-negative bacteria	7
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	7
Molecular diagnostic methods for pneumonia: how can they be applied in practice?	7
Tick-borne encephalitis	7
Resistance in Enteric Shigella and nontyphoidal Salmonella: emerging concepts	7
Biomarkers in sepsis: can they help improve patient outcome?	7
The role of Gram-negative bacteria in skin and soft tissue infections	7
Community-acquired skin and soft-tissue infections in people who inject drugs	7
Coronavirus disease 2019 in children	7
Neonatal bloodstream infections	7
Skin and soft tissue infections due to rapidly growing mycobacteria	7
How common is ventilator-associated pneumonia after coronavirus disease 2019?	6
The intracellular phase of extracellular respiratory tract bacterial pathogens and its role on pathogen-host interactions during infection	6
New antibiotics for the treatment of nonfermenting Gram-negative bacteria	6
Global health security as it pertains to Zika, Ebola, and COVID-19	6
New management approaches to tuberculosis in people living with HIV	6
When should we use corticosteroids in severe community-acquired pneumonia?	6
Transplantation for chagas’ disease: closing the knowledge gap	6
Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections	6
Epidemiology of Gram-negative bacteria during coronavirus disease 2019. What is the real pandemic?	6
Current management of necrotizing soft-tissue infections	6
Prevention strategies for congenital cytomegalovirus infection	6
Radiology-based diagnosis of fungal pulmonary infections in high-risk hematology patients: are we making progress?	6
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	6
Progress and challenges in human papillomavirus and cervical cancer in southern Africa	6
Biomarkers to predict cardiovascular disease in people living with HIV	6
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	6
Recent concepts in fungal involvement in skin and soft tissue infections	6
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy	6
The microbiota in respiratory tract infections: from association to intervention	6
Congenital Chagas disease: progress toward implementation of pregnancy-based screening	6
Antibiotic treatment of acute bacterial skin and skin structure infections	6
Host transcriptional signatures as predictive markers of infection in children	6
Central nervous system infections after solid organ transplantation	6
The disease burden of respiratory syncytial virus in Infants	6
Treatment approaches for severe Stenotrophomonas maltophilia infections	5
The implications of the COVID-19 pandemic for long term care facilities	5
Current viewpoint on the epidemiology of nonfermenting Gram-negative bacterial strains	5
Gambiense human African trypanosomiasis: the bumpy road to elimination	5
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	5
Contributions of Yersinia pestis outer membrane protein Ail to plague pathogenesis	5
Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	5
Resistant herpes simplex virus infections – who, when, and what's new?	5
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?	5
Clinical evidence supporting cefiderocol for serious Acinetobacter baumannii infections	5
Management of nonfermenting gram-negative infections: a critique of the guidelines	5
The impact of alteration in gut microbiome in the pathogenesis of nonalcoholic fatty liver disease	5
New evidence for managing Gram-negative bloodstream infections	5
New approaches to management of fever and neutropenia in high-risk patients	5
A new era of HIV care for age-associated multimorbidity	5
Skin and soft tissue infections in the elderly	5
Gut microbiome and its clinical implications: exploring the key players in human health	4
Gram-negative bacteria as a cause of mediastinitis after cardiac surgery	4
Percutaneous treatment of liver hydatid cysts: to PAIR or not to PAIR	4
Controversies over the management of infections caused by Amp-C- and ESBL-producing Enterobacterales: what questions remain for future studies?	4
Burden of influenza in the elderly: a narrative review	4
Cotrimoxazole and clindamycin in skin and soft tissue infections	4
Defer no more: advances in the treatment and prevention of chronic hepatitis C virus infection in children	4
Human herpesvirus 8 and Kaposi sarcoma: how should we screen and manage the transplant recipient?	4
Diagnostic approach and update on encephalitis	4
Brain abscess in immunocompetent patients: recent findings	4

Pulmonary cystic echinococcosis	4
The future of Clostridioides difficile diagnostics	4
How different is invasive fusariosis in pediatric patients than in adults? A systematic review	4
Sequence-based diagnostics and precision medicine in bacterial and viral infections: from bench to bedside	4
Gastrointestinal manifestations of coronavirus disease 2019	4
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	4
Infant feeding: emerging concepts to prevent HIV transmission	4
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	4
Donors with human immunodeficiency virus and hepatitis C virus for solid organ transplantation: what's new	4
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	4
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	4
How to manage skin and soft-tissue infections in the emergency department	4
Machine learning and artificial intelligence for the diagnosis of infectious diseases in immunocompromised patients	4
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	4
Updates in central nervous system malaria: literature review and considerations	3
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients	3
Novel techniques in the treatment of skin and soft tissue infection	3
Novel approaches to the prediction and diagnosis of pulmonary complications in the paediatric haematopoietic stem cell transplant patient	3
Modeling transmission of pathogens in healthcare settings	3
Defining effective durations of antibiotic therapy for community-acquired pneumonia and urinary tract infections in hospitalized children	3
What is the clinical significance of ‘heteroresistance’ in nonfermenting Gram-negative strains?	3
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	3
The impact of coronavirus disease 2019 on people with HIV	3
Inclusion, diversity, access, and equity in antimicrobial stewardship: where we are and where we are headed	3
Evidence supporting the use of therapeutic drug monitoring of ganciclovir in transplantation	3
Wastewater-based epidemiology for surveillance of infectious diseases in healthcare settings	3
Clinical and microbiological characteristics of Staphylococcus lugdunensis	3
Management strategies for severe Pseudomonas aeruginosa infections	3
Short treatment duration for community-acquired pneumonia	3
The eternal dilemma of antitoxin antibiotics for skin and soft tissue infection	3
Update on the treatment of chronic pulmonary aspergillosis	3
Duration of antibiotic therapy for Enterobacterales and Pseudomonas aeruginosa: a review of recent evidence	3
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	3
Necrotizing fasciitis: an update on epidemiology, diagnostic methods, and treatment	3
Bacteriophages against enteropathogens: rediscovery and refinement of novel antimicrobial therapeutics	3
COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US	3
Navigating the unknown: the coronavirus disease 2019 pandemic and solid organ transplantation	3
Where was my patient born? The Intersection of tropical medicine and migrant health	3
Microbiotoxicity: antibiotic usage and its unintended harm to the microbiome	3
Recent advances in Clostridioides difficile infection epidemiology, diagnosis and treatment in children	3
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	3